Publication | Open Access
Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results
23
Citations
12
References
2022
Year
Clinical ImmunologyInflammationComplement SystemLaboratory ImmunologyPathogenesisImmunologyHumoral ResponseAutoimmunityDurable ResponseImmunologic DiseaseImmunosuppressionImmunotherapyMedicineSutimlimab ResultsComplement C1s Inhibition
Not available.
| Year | Citations | |
|---|---|---|
Page 1
Page 1